Nationwide Evidence-Based Treatment

Dual Diagnosis Treatment for Co-Occurring Disorders

Our dual diagnosis treatment programs address both substance use and underlying mental health conditions through integrated, clinically coordinated care. By combining psychiatric services, evidence-based therapy, and addiction treatment, we help individuals achieve stability and sustainable recovery.

Verify Insurance Coverage
Call (302) 555-1234

Confidential. Free assessment. Most insurance accepted.

Nationwide Evidence-Based Treatment

Dual Diagnosis Treatment for Co-Occurring Disorders

Our dual diagnosis treatment programs address both substance use and underlying mental health conditions through integrated, clinically coordinated care. By combining psychiatric services, evidence-based therapy, and addiction treatment, we help individuals achieve stability and sustainable recovery.

Verify Insurance Coverage
Call (302) 555-1234
  • Available 24/7
  • HIPAA Compliant
  • No Obligation

Confidential. Free assessment. Most insurance accepted.

15+

Years of Service

5000+

Lives Transformed

92%

Completion Rate

24/7

Support Availiable

Evidence-Based

Clinical Protocols
NIDA-aligned treatment approaches

Dual Diagnosis

Expertise
Integrated mental health & addiction care

Individualized

Treatment Planning
Tailored to each clinical profile

Nationwide

Care Network
Facilities across the United States

Co-Occurring Disorders

The term dual diagnosis – clinically referred to as co-occurring disorders – describes the simultaneous presence of at least one substance use disorder (SUD) and at least one mental health disorder in the same individual. This is not an uncommon clinical presentation: co-occurring conditions are frequently diagnosed together, and each disorder can significantly affect the course and severity of the other.

According to the Substance Abuse and Mental Health Services Administration (SAMHSA), co-occurring disorders encompass a broad range of combinations – including depressive disorders, anxiety disorders, post-traumatic stress disorder (PTSD), bipolar disorder, and psychotic disorders co-occurring alongside alcohol use disorder, opioid use disorder, stimulant use disorder, and other substance-related conditions.

Diagnosing co-occurring disorders presents clinical complexity. Some psychiatric symptoms – such as depressive episodes, anxiety, or perceptual disturbances – may be substance-induced and resolve with abstinence, while others may reflect independent psychiatric conditions requiring ongoing treatment. A thorough, multi-faceted clinical evaluation is essential to distinguish between these presentations and to develop an appropriate, individualized care plan.

Key Clinic Facts

~9.2M

U.S. adults estimated to have co-occurring disorders annually (SAMHSA)

2x

Increased likelihood of SUD among individuals with a mental health disorder (NIDA)

Integrated

Care model recommended by SAMHSA, NIDA, NIMH & APA as standard of care

Conditions Frequently Seen Together

While virtually any combination of substance use disorder and mental health condition can co-occur, certain combinations are more commonly identified in clinical populations. Understanding the nature of these relationships can inform both recognition and treatment.

PTSD and Substance Use

Post-traumatic stress disorder (PTSD) and substance use disorders are highly prevalent co-occurring conditions, particularly among combat veterans, survivors of interpersonal violence, and individuals who experienced significant childhood adversity. Substances may be used in an attempt to manage intrusive memories, hyperarousal, sleep disturbances, and emotional numbing associated with PTSD.

Trauma-focused, integrated treatment models – such as Seeking Safety and trauma-focused CBT delivered in conjunction with substance use treatment – have demonstrated clinical efficacy in addressing both conditions simultaneously. The VA/DoD Clinical Practice Guidelines and SAMHSA both highlight the importance of trauma-informed care in the context of co-occurring SUD.

Learn About PTSD

Depression and Substance Use

Major depressive disorder and persistent depressive disorder are among the most commonly co-occurring mental health conditions alongside substance use disorders. Individuals with depression may use alcohol or other substances in an attempt to self-medicate feelings of sadness, hopelessness, or emotional numbness. Conversely, heavy alcohol use in particular can deplete neurotransmitters associated with mood regulation, deepening depressive symptoms over time.

Integrated treatment for depression and SUD typically involves psychotherapy – such as Cognitive Behavioral Therapy (CBT) – alongside medication management when clinically indicated, and evidence-based substance use interventions.

Depression

Anxiety Disorders

Anxiety disorders – including generalized anxiety disorder, social anxiety disorder, and panic disorder – frequently co-occur with alcohol use disorder and sedative use disorder. Individuals may use these substances to temporarily reduce anxiety symptoms, which can establish a cycle of dependence and symptom escalation. Stimulant use can also exacerbate anxiety and panic symptoms over time.

Distinguishing between substance-induced anxiety and an independent anxiety disorder is a critical component of clinical assessment. Evidence-based psychotherapies, including CBT and exposure-based treatments, are central to integrated care for co-occurring anxiety and SUD.

Anxiety

Bipolar Disorder

Bipolar disorder has among the highest rates of co-occurring substance use disorder of any psychiatric condition. Substance use during manic or depressive episodes can significantly complicate the clinical picture, making accurate diagnosis more challenging and increasing safety risks. Integrated treatment that addresses mood stabilization alongside substance use disorder is essential to effective care for this population. Any specific medication or diagnostic decisions for bipolar disorder should be made in close consultation with a licensed psychiatrist or addiction medicine specialist.

Health Consequences

Risks of Treating Conditions Separately

Historically, substance use disorders and mental health conditions were treated separately, often in different settings by different clinical teams with limited communication. Evidence has consistently demonstrated that this siloed approach leads to inferior outcomes compared to integrated, coordinated treatment.

HIGH RISK

Increased Relapse Risk

Unaddressed psychiatric symptoms are a well-established precipitant of substance use relapse. Without concurrent mental health treatment, the drivers of substance use remain active.
MODERATE-HIGH

Untreated Psychiatric Symptoms

When mental health conditions go unaddressed during substance use treatment, symptom burden persists and can undermine treatment engagement and recovery.
ACUTE RISK

Medication Management Challenges

Ongoing substance use can interfere with the efficacy and safety of psychiatric medications. Uncoordinated care increases the risk of adverse medication interactions.
MODERATE

Higher Hospitalization Rates

Research indicates that individuals with untreated co-occurring disorders experience higher rates of psychiatric hospitalization and emergency department utilization.
Diagnostic Categories

Health Risks Associated With Co-Occurring Disorders

The simultaneous presence of a substance use disorder and a mental health condition is associated with a range of elevated health risks. Clinical awareness of these risks is an important component of comprehensive dual diagnosis care.

Elevated Overdose Risk

Individuals with co-occurring psychiatric conditions – particularly mood disorders and PTSD – face increased risk of intentional or unintentional overdose. Psychiatric crises can impair judgment and behavioral inhibition, while some psychiatric medications may interact pharmacologically with substances of misuse. Medication-assisted treatment programs and integrated clinical monitoring are important components of overdose risk reduction.

Suicide Risk

Co-occurring substance use disorder and depression, bipolar disorder, or PTSD is associated with elevated suicide risk compared to either condition alone. Suicidal ideation or behavior requires immediate clinical attention. If you or someone you know is experiencing suicidal thoughts, please contact emergency services or a crisis resource immediately.

Adverse Medication Interactions

Substance use can alter the metabolism, efficacy, and safety profile of psychiatric medications. Coordinated clinical oversight – with the treating psychiatrist, primary care provider, and addiction medicine team communicating – is essential to minimizing pharmacological risks.

Impaired Judgment and Decision-Making

Active psychiatric symptoms and substance intoxication or withdrawal each independently impair cognitive and executive functioning. Together, they can significantly compromise an individual's capacity to engage safely in daily activities, treatment planning, and health-related decision-making.

Medical Emergency Notice

If you or someone you know is experiencing severe withdrawal symptoms – call 911 immediately. These symptoms represent a medical emergency. Do not attempt to manage them at home.

How the Admissions Process Works

Getting started is straightforward and confidential. Our admissions team is available around the clock to guide you through each step.
1

Confidential Assessment

Speak with our admissions team for a free, no-obligation clinical assessment to determine the appropriate level of care.

2

Insurance Verification

We verify your benefits and explain coverage details, out-of-pocket costs, and available financial options.

3

Personalized Treatment Plan

Our clinical team develops an individualized plan addressing substance use, mental health, and recovery goals.

4

Begin Treatment

Start your recovery journey with medical, therapeutic, and peer support from day one. Same-day admissions may be available.

Treatment Programs & Services

We offer a full continuum of care, from initial stabilization through long-term recovery support. Each program is guided by ASAM placement criteria and current clinical best practices.

Inpatient Rehabilitation

Structured, residential clinical care

24-hour supervised care in a medically managed residential environment for individuals with moderate to severe substance use disorders requiring intensive clinical support.

  • Appropriate for: Severe addiction, medical detox needs, unstable home environment
  • Duration: Typically 30–90 days
  • Components: Medical supervision, individual & group therapy, medication management
Learn More

Outpatient Programs

Flexible therapy-based care

Flexible, therapy-based care that allows individuals to continue living at home while receiving structured clinical support and evidence-based treatment services.

  • Appropriate for: Mild to moderate symptoms, strong support system, step-down from inpatient
  • Duration: 3-12 months
  • Components: Individual therapy, group sessions, relapse prevention, family counseling
Learn More

Dual-Diagnosis Treatment

Integrated mental health + addiction care

Integrated treatment for co-occurring substance use and mental health disorders. Research consistently demonstrates that simultaneous treatment of both conditions improves outcomes.

  • Appropriate for: Co-occurring depression, anxiety, PTSD, bipolar disorder with substance use
  • Duration: Varies by clinical assessment
  • Components: Psychiatric evaluation, integrated therapy, medication management
Learn More

Medication-Assisted Treatment

FDA-approved medications + therapy

FDA-approved medications combined with counseling and behavioral therapies to provide a whole-patient approach to substance use disorder treatment.

  • Appropriate for: Opioid use disorder, alcohol use disorder, withdrawal management
  • Duration: Individualized; may be ongoing
  • Components: Buprenorphine, methadone, or naltrexone combined with behavioral counseling
Learn More

Medical Detoxification

Safe withdrawal + 24/7 clinical supervision

Medical detox provides a safe, monitored environment to manage withdrawal symptoms as the body clears itself of substances. This process minimizes physical risks and ensures patient comfort before transitioning to ongoing therapy.

  • Appropriate for: Severe alcohol, opioid, or prescription drug dependence requiring medical intervention
  • Duration: 3 to 10 days, depending on the substance and severity
  • Components: 24/7 medical monitoring, medication-assisted treatment, withdrawal symptom management, transition planning
Learn More

Insurance Coverage & Financial Options

The Mental Health Parity and Addiction Equity Act requires most insurance plans to cover substance use disorder treatment at parity with medical and surgical care. Beacon Addiction Care accepts most major insurance providers.

Our financial counselors work with each patient and family to maximize insurance benefits, explain out-of-pocket costs, and identify additional resources including state-funded programs and sliding-scale options.

Contact Us Today (302) 555-1234

Accepted Insurance Providers

  • Aetna
  • Cigna
  • Humana
  • Medicaid
  • TRICARE
  • BlueCross BlueShield
  • UnitedHealthcare
  • Kaiser Permanente
  • Medicare
  • Anthem

Don’t see your provider? Contact us – we work with most plans.

Frequently Asked Questions

The following questions address common topics related to dual diagnosis. All answers are for educational purposes only. For guidance specific to your situation, please consult a qualified healthcare professional.

Dual diagnosis – also referred to as co-occurring disorders – is a clinical term that describes the simultaneous presence of a substance use disorder (SUD) and one or more mental health disorders in the same individual. Common examples include depression with alcohol use disorder, PTSD with opioid use disorder, or anxiety disorders alongside stimulant use. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), co-occurring disorders require integrated, coordinated treatment that addresses both conditions concurrently rather than in isolation.

Co-occurring disorders are significantly prevalent across the United States. SAMHSA’s National Survey on Drug Use and Health consistently reports that millions of U.S. adults experience both a mental illness and a substance use disorder in the same year. Research from the National Institute on Drug Abuse (NIDA) indicates that people with substance use disorders are roughly twice as likely to have a co-occurring mood or anxiety disorder compared to the general population. Despite this, a substantial proportion of affected individuals receive treatment for only one condition, or no treatment at all.

The relationship between mental illness and substance use disorder is bidirectional and complex. Mental health conditions can increase vulnerability to substance use – for instance, individuals experiencing untreated depression, anxiety, or trauma may use substances to temporarily relieve symptoms. Conversely, chronic or heavy substance use can alter brain chemistry and neurological function in ways that contribute to the onset or worsening of psychiatric symptoms. Some research also suggests shared genetic, environmental, and developmental risk factors may predispose individuals to both types of conditions. The National Institute of Mental Health (NIMH) and NIDA both emphasize that neither condition should be viewed as simply causing the other; instead, they interact dynamically and must be assessed and treated together.

Treating a substance use disorder without addressing co-occurring mental health conditions or vice versa is associated with significantly poorer clinical outcomes. Untreated psychiatric symptoms can drive relapse, while ongoing substance use can destabilize psychiatric treatment. Integrated treatment – in which a coordinated clinical team addresses both conditions simultaneously – is strongly recommended by SAMHSA, NIDA, and the American Psychiatric Association (APA) as the evidence-based standard of care for co-occurring disorders. Integrated approaches reduce the risk of relapse, improve treatment retention, and support long-term recovery and wellness.

Evidence-based psychotherapies commonly used in dual diagnosis treatment include Cognitive Behavioral Therapy (CBT), which helps individuals identify and modify maladaptive thought patterns and behaviors related to both substance use and mental health symptoms; Trauma-Focused Therapies such as Cognitive Processing Therapy (CPT) and EMDR for individuals with PTSD and co-occurring SUDs; and Motivational Interviewing (MI), which supports individuals in building readiness for change. Dialectical Behavior Therapy (DBT) and Integrated Dual Disorder Treatment (IDDT) may also be employed depending on clinical presentation and level of care. Medication-assisted treatment (MAT) may be incorporated where clinically appropriate.

Under the Mental Health Parity and Addiction Equity Act (MHPAEA), health insurance plans that cover mental health and substance use disorder treatment must generally do so at parity with medical and surgical benefits. This means that integrated dual diagnosis programs – including inpatient, residential, and outpatient levels of care – may be covered under many commercial insurance plans, Medicaid, and Medicare. Coverage details vary by plan, and preauthorization may be required. We recommend contacting your insurance carrier or speaking with a benefits specialist to understand your specific coverage.

The appropriate level of care depends on a comprehensive clinical assessment of symptom severity, safety considerations, functional impairment, and the presence of any medical or psychiatric conditions requiring close monitoring. Options range from medical detoxification (for those experiencing withdrawal) to inpatient/residential treatment (providing 24-hour psychiatric and medical supervision) to intensive outpatient (IOP) and standard outpatient programs (for individuals with greater stability and social support). A licensed clinician conducts a structured assessment – using tools such as the ASAM Criteria – to determine the most appropriate and least restrictive level of care based on each individual’s clinical needs.

Seek emergency support immediately if you or someone you know is experiencing thoughts of suicide or self-harm, is in a psychiatric emergency, or is at risk of overdose or withdrawal complications. Call 911 for immediate, life-threatening emergencies. For emotional crisis support anywhere in the United States, call or text 988 (Suicide & Crisis Lifeline), available 24 hours a day, 7 days a week. If you believe someone may have overdosed, call 911 immediately and administer naloxone if available. Do not leave the person alone.

Reviewed by Rebecca Thompson, RN

Board-Certified in Addiction Medicine | Nursing Director
Last Updated: February 2026

Sources & Citations:

Reviewed by Rebecca Thompson, RN

Board-Certified in Addiction Medicine | Nursing Director
Last Updated: February 2026

Sources & Citations:

Medical Disclaimer: The information on this page is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition or treatment options.

Confidentiality Notice: Beacon Addiction Care is committed to protecting your privacy. All communications are handled in accordance with HIPAA (Health Insurance Portability and Accountability Act) regulations and 42 CFR Part 2 federal confidentiality requirements for substance use disorder treatment records.

Beacon Addiction Care does not guarantee specific treatment outcomes. Individual results vary based on the nature and severity of the substance use disorder, co-occurring conditions, and adherence to the treatment plan.

Integrated Care Can Address Both Mental Health and Substance Use

When mental health conditions and substance use disorders are treated together through a coordinated, evidence-based approach, individuals have access to more comprehensive and effective care. Our care specialists are available to discuss your options confidentially.
Start A self-Assesment (302) 555-1234

Available 24/7 · HIPAA Compliant · No Obligation